Published in PLoS One on July 09, 2009
Manganese-induced atypical parkinsonism is associated with altered Basal Ganglia activity and changes in tissue levels of monoamines in the rat. PLoS One (2014) 0.77
Dopaminergic control of the globus pallidus through activation of D2 receptors and its impact on the electrical activity of subthalamic nucleus and substantia nigra reticulata neurons. PLoS One (2015) 0.76
Parallel organization of functionally segregated circuits linking basal ganglia and cortex. Annu Rev Neurosci (1986) 18.17
The functional anatomy of basal ganglia disorders. Trends Neurosci (1989) 12.28
Primate models of movement disorders of basal ganglia origin. Trends Neurosci (1990) 7.63
Functional anatomy of the basal ganglia. II. The place of subthalamic nucleus and external pallidum in basal ganglia circuitry. Brain Res Brain Res Rev (1995) 3.32
Positron emission tomographic analysis of central D1 and D2 dopamine receptor occupancy in patients treated with classical neuroleptics and clozapine. Relation to extrapyramidal side effects. Arch Gen Psychiatry (1992) 2.84
Neurotransmitters and neuromodulators in the basal ganglia. Trends Neurosci (1990) 2.83
Cortical inputs and GABA interneurons imbalance projection neurons in the striatum of parkinsonian rats. J Neurosci (2006) 2.64
Relationship between dopamine D(2) occupancy, clinical response, and side effects: a double-blind PET study of first-episode schizophrenia. Am J Psychiatry (2000) 2.61
GABAergic microcircuits in the neostriatum. Trends Neurosci (2004) 2.47
Feedforward inhibition of projection neurons by fast-spiking GABA interneurons in the rat striatum in vivo. J Neurosci (2005) 2.30
Molecular effects of dopamine on striatal-projection pathways. Trends Neurosci (2000) 1.73
Dopamine D4 receptor-knock-out mice exhibit reduced exploration of novel stimuli. J Neurosci (1999) 1.69
Burst and oscillation as disparate neuronal properties. J Neurosci Methods (1996) 1.58
Central D2-dopamine receptor occupancy in schizophrenic patients treated with antipsychotic drugs. Arch Gen Psychiatry (1988) 1.38
The pars reticulata of the substantia nigra: a window to basal ganglia output. Prog Brain Res (2007) 1.23
The output neurones and the dopaminergic neurones of the substantia nigra receive a GABA-containing input from the globus pallidus in the rat. J Comp Neurol (1990) 1.12
Increased subthalamic neuronal activity after nigral dopaminergic lesion independent of disinhibition via the globus pallidus. Neuroscience (1996) 1.09
Effects of L-DOPA on neuronal activity of the globus pallidus externalis (GPe) and globus pallidus internalis (GPi) in the MPTP-treated monkey. Brain Res (1998) 1.08
Catalepsy and circling behaviour after intracerebral injections of neuroleptic, cholinergic and anticholinergic agents into the caudate-putamen, globus pallidus and substantia nigra of rat brain. Neuropharmacology (1972) 1.02
Substantia nigra pars reticulata single unit activity in normal and 60HDA-lesioned rats: effects of intrastriatal apomorphine and subthalamic lesions. Synapse (1997) 1.00
Changes in the firing pattern of globus pallidus neurons after the degeneration of nigrostriatal pathway are mediated by the subthalamic nucleus in the rat. Eur J Neurosci (2000) 0.98
Reduction of apomorphine-induced rotational behaviour by subthalamic lesion in 6-OHDA lesioned rats is associated with a normalization of firing rate and discharge pattern of pars reticulata neurons. Exp Brain Res (1995) 0.97
Evaluation of dopamine D-2 receptor occupancy by clozapine, risperidone, and haloperidol in vivo in the rodent and nonhuman primate brain using 18F-fallypride. Neuropsychopharmacology (2001) 0.97
Catalepsy induced by a blockade of dopamine D1 or D2 receptors was reversed by a concomitant blockade of adenosine A(2A) receptors in the caudate-putamen of rats. Eur J Neurosci (2001) 0.96
Neurons of the substantia nigra reticulata receive a dense GABA-containing input from the globus pallidus in the rat. Brain Res (1989) 0.94
Haloperidol-induced catalepsy is absent in dopamine D(2), but maintained in dopamine D(3) receptor knock-out mice. Eur J Pharmacol (2000) 0.94
Occupancy of dopamine D(1), D (2) and serotonin (2A) receptors in schizophrenic patients treated with flupentixol in comparison with risperidone and haloperidol. Psychopharmacology (Berl) (2006) 0.93
Chronic treatment with dopamine receptor antagonists: behavioral and pharmacologic effects on D1 and D2 dopamine receptors. J Neurosci (1988) 0.90
Noradrenergic modulation of subthalamic nucleus activity: behavioral and electrophysiological evidence in intact and 6-hydroxydopamine-lesioned rats. J Neurosci (2007) 0.90
Similar effects of D(1)/D(2) receptor blockade on feeding and locomotor behavior. Pharmacol Biochem Behav (2000) 0.89
Neuroleptic affinities for human brain receptors and their use in predicting adverse effects. J Clin Psychiatry (1984) 0.89
Dopamine D1 or D2 receptor blockade in the globus pallidus produces akinesia in the rat. Behav Brain Res (1999) 0.84
PET analysis indicates atypical central dopamine receptor occupancy in clozapine-treated patients. Br J Psychiatry Suppl (1992) 0.84
A new rodent model for neuroleptic-induced pseudo-parkinsonism: low doses of haloperidol increase forelimb tremor in the rat. Behav Neurosci (1990) 0.84
Intrapallidal dopamine restores motor deficits induced by 6-hydroxydopamine in the rat. J Neural Transm (Vienna) (2001) 0.83
Consequences of partial and severe dopaminergic lesion on basal ganglia oscillatory activity and akinesia. Eur J Neurosci (2005) 0.83
D2 antagonist-induced c-fos in an identified subpopulation of globus pallidus neurons by a direct intrapallidal action. Brain Res (2003) 0.82
The Effects of Activation or Inhibition of the Subthalamic Nucleus on the Metabolic and Electrophysiological Activities Within the Pallidal Complex and Substantia Nigra in the Rat. Eur J Neurosci (1991) 0.81
The role of the globus pallidus D2 subfamily of dopamine receptors in pallidal immediate early gene expression. Neuroscience (2001) 0.81
The effects of globus pallidus lesions on dopamine-dependent motor behaviour in rats. Neuroscience (1998) 0.80
Enhanced cortical dopamine output and antipsychotic-like effect of raclopride with adjunctive low-dose L-dopa. Biol Psychiatry (2005) 0.79
Parametric influences on catalepsy. Psychopharmacology (Berl) (1984) 0.79
Glutamate decarboxylase messenger RNA in rat pallidum: comparison of the effects of haloperidol, clozapine and combined haloperidol-scopolamine treatments. Neuroscience (1995) 0.79
Biomechanical and electromyogram characterization of neuroleptic-induced rigidity in the rat. Neuroscience (2007) 0.78
Differing influences of dopamine agonists and antagonists on Fos expression in identified populations of globus pallidus neurons. Neuroscience (1997) 0.77
Responses of rat substantia nigra pars reticulata units to cortical stimulation. Neurosci Lett (1992) 0.77
Thiothixene and the thioxanthenes. Adv Biochem Psychopharmacol (1974) 0.76
Cholinergic and neuroleptic induced catalepsy: modification by lesions in the globus pallidus and substantia nigra. Neuropharmacology (1971) 0.76
A biphasic influence of globus pallidus lesions: spontaneous catalepsy followed by anticataleptic effect. Pharmacol Biochem Behav (1983) 0.76
Five-year follow-up of bilateral stimulation of the subthalamic nucleus in advanced Parkinson's disease. N Engl J Med (2003) 6.59
Cortical inputs and GABA interneurons imbalance projection neurons in the striatum of parkinsonian rats. J Neurosci (2006) 2.64
Presymptomatic compensation in Parkinson's disease is not dopamine-mediated. Trends Neurosci (2003) 2.41
Subthalamic high frequency stimulation resets subthalamic firing and reduces abnormal oscillations. Brain (2005) 2.19
Deep brain stimulation of the ventral caudate nucleus in the treatment of obsessive-compulsive disorder and major depression. Case report. J Neurosurg (2004) 2.09
The effects of coffee and napping on nighttime highway driving: a randomized trial. Ann Intern Med (2006) 2.04
Sleep disorders in Parkinson's disease: the contribution of the MPTP non-human primate model. Exp Neurol (2009) 1.70
Increased D1 dopamine receptor signaling in levodopa-induced dyskinesia. Ann Neurol (2005) 1.65
Fatigue, sleep restriction and driving performance. Accid Anal Prev (2005) 1.60
High-frequency stimulation in Parkinson's disease: more or less? Trends Neurosci (2005) 1.59
Neuronal correlates of obsessions in the caudate nucleus. Biol Psychiatry (2007) 1.58
Meta-analysis of brain volume changes in obsessive-compulsive disorder. Biol Psychiatry (2008) 1.55
Continuous positive airway pressure for sleep-related breathing disorders in multiple system atrophy: long-term acceptance. Sleep Med (2005) 1.50
Validation of Horne and Ostberg morningness-eveningness questionnaire in a middle-aged population of French workers. J Biol Rhythms (2004) 1.47
Deep brain stimulation for Parkinson's disease: potential risk of tissue damage associated with external stimulation. Ann Neurol (2004) 1.42
Pathophysiology of obsessive-compulsive disorder: a necessary link between phenomenology, neuropsychology, imagery and physiology. Prog Neurobiol (2004) 1.40
Latest view on the mechanism of action of deep brain stimulation. Mov Disord (2008) 1.39
Provocation of obsessive-compulsive symptoms: a quantitative voxel-based meta-analysis of functional neuroimaging studies. J Psychiatry Neurosci (2008) 1.39
Sleep disorders and accidental risk in a large group of regular registered highway drivers. Sleep Med (2010) 1.31
Dual effect of high-frequency stimulation on subthalamic neuron activity. J Neurosci (2003) 1.30
Effects of sleep deprivation on Color-Word, Emotional, and Specific Stroop interference and on self-reported anxiety. Brain Cogn (2005) 1.30
The circadian and homeostatic modulation of sleep pressure during wakefulness differs between morning and evening chronotypes. J Sleep Res (2003) 1.29
Late emergence of synchronized oscillatory activity in the pallidum during progressive Parkinsonism. Eur J Neurosci (2007) 1.27
Shaping of motor responses by incentive values through the basal ganglia. J Neurosci (2007) 1.24
From single extracellular unit recording in experimental and human Parkinsonism to the development of a functional concept of the role played by the basal ganglia in motor control. Prog Neurobiol (2002) 1.17
Age, performance and sleep deprivation. J Sleep Res (2004) 1.17
Enriched environment confers resistance to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine and cocaine: involvement of dopamine transporter and trophic factors. J Neurosci (2003) 1.16
Dynamic changes in the cortex-basal ganglia network after dopamine depletion in the rat. J Neurophysiol (2008) 1.15
Fatigue, sleepiness, and performance in simulated versus real driving conditions. Sleep (2005) 1.14
Pathogenesis of levodopa-induced dyskinesia: focus on D1 and D3 dopamine receptors. Parkinsonism Relat Disord (2005) 1.13
Gray matter alterations in obsessive-compulsive disorder: an anatomic likelihood estimation meta-analysis. Neuropsychopharmacology (2009) 1.12
Serotonergic neurons mediate ectopic release of dopamine induced by L-DOPA in a rat model of Parkinson's disease. Neurobiol Dis (2010) 1.11
Deep brain stimulation: what does it offer? Adv Neurol (2003) 1.09
A new ATP-sensitive K+ channel-independent mechanism is involved in glucose-excited neurons of mouse arcuate nucleus. Diabetes (2004) 1.09
D5 (not D1) dopamine receptors potentiate burst-firing in neurons of the subthalamic nucleus by modulating an L-type calcium conductance. J Neurosci (2003) 1.06
Chronic L-DOPA therapy alters central serotonergic function and L-DOPA-induced dopamine release in a region-dependent manner in a rat model of Parkinson's disease. Neurobiol Dis (2010) 1.02
Involvement of sensorimotor, limbic, and associative basal ganglia domains in L-3,4-dihydroxyphenylalanine-induced dyskinesia. J Neurosci (2005) 1.01
5-HT1A receptor agonist-mediated protection from MPTP toxicity in mouse and macaque models of Parkinson's disease. Neurobiol Dis (2006) 1.00
Striatal overexpression of DeltaJunD resets L-DOPA-induced dyskinesia in a primate model of Parkinson disease. Biol Psychiatry (2009) 1.00
Aging and nocturnal driving: better with coffee or a nap? A randomized study. Sleep (2007) 1.00
Levodopa-induced dyskinesia in MPTP-treated macaques is not dependent on the extent and pattern of nigrostrial lesioning. Eur J Neurosci (2005) 1.00
Enhanced preproenkephalin-B-derived opioid transmission in striatum and subthalamic nucleus converges upon globus pallidus internalis in L-3,4-dihydroxyphenylalanine-induced dyskinesia. Biol Psychiatry (2006) 1.00
Increased slow oscillatory activity in substantia nigra pars reticulata triggers abnormal involuntary movements in the 6-OHDA-lesioned rat in the presence of excessive extracellular striatal dopamine. Neurobiol Dis (2006) 0.99
Impact of high-frequency stimulation parameters on the pattern of discharge of subthalamic neurons. J Neurophysiol (2005) 0.99
Fatigue, sleep restriction, and performance in automobile drivers: a controlled study in a natural environment. Sleep (2003) 0.99
Acute versus chronic partial sleep deprivation in middle-aged people: differential effect on performance and sleepiness. Sleep (2012) 0.98
Deep brain stimulation for OCD and major depression. Am J Psychiatry (2005) 0.98
Time-course of nigrostriatal degeneration in a progressive MPTP-lesioned macaque model of Parkinson's disease. Mol Neurobiol (2003) 0.96
Sleepiness, near-misses and driving accidents among a representative population of French drivers. J Sleep Res (2010) 0.95
Maintenance of wakefulness test as a predictor of driving performance in patients with untreated obstructive sleep apnea. Sleep (2007) 0.95
Sharp and sleepy: evidence for dissociation between sleep pressure and nocturnal performance. J Sleep Res (2008) 0.94
High-frequency stimulation of the subthalamic nucleus and L-3,4-dihydroxyphenylalanine inhibit in vivo serotonin release in the prefrontal cortex and hippocampus in a rat model of Parkinson's disease. J Neurosci (2010) 0.94
Rise and fall of minocycline in neuroprotection: need to promote publication of negative results. Exp Neurol (2004) 0.94
A nationwide survey of excessive daytime sleepiness in Parkinson's disease in France. Mov Disord (2007) 0.94
Noradrenaline and Parkinson's disease. Front Syst Neurosci (2011) 0.94
Updated overview of the putative role of the serotoninergic system in obsessive-compulsive disorder. Neuropsychiatr Dis Treat (2005) 0.93
Maintenance of Wakefulness Test, obstructive sleep apnea syndrome, and driving risk. Ann Neurol (2008) 0.93
Sleep duration and caffeine consumption in a French middle-aged working population. Sleep Med (2005) 0.92
Anatomical alterations and symptom-related functional activity in obsessive-compulsive disorder are correlated in the lateral orbitofrontal cortex. Biol Psychiatry (2009) 0.91
Extended driving impairs nocturnal driving performances. PLoS One (2008) 0.91
Distinct striatal targets in treating obsessive-compulsive disorder and major depression. J Neurosurg (2009) 0.91
Noradrenergic modulation of subthalamic nucleus activity: behavioral and electrophysiological evidence in intact and 6-hydroxydopamine-lesioned rats. J Neurosci (2007) 0.90
Temporal and spatial alterations in GPi neuronal encoding might contribute to slow down movement in Parkinsonian monkeys. Eur J Neurosci (2006) 0.90
Primate models of dystonia. Prog Neurobiol (2008) 0.90
Altered pallido-pallidal synaptic transmission leads to aberrant firing of globus pallidus neurons in a rat model of Parkinson's disease. J Physiol (2012) 0.90
Nigrostriatal lesion induces D2-modulated phase-locked activity in the basal ganglia of rats. Eur J Neurosci (2007) 0.90
Neuroprotective strategies for Parkinson's disease: conceptual limits of animal models and clinical trials. Trends Pharmacol Sci (2004) 0.89
Evolution of the dynamic properties of the cortex-basal ganglia network after dopaminergic depletion in rats. Neurobiol Dis (2012) 0.89
Synchronous high-voltage spindles in the cortex-basal ganglia network of awake and unrestrained rats. Eur J Neurosci (2007) 0.89
Imaging of subthalamic nucleus and ventralis intermedius of the thalamus. Mov Disord (2002) 0.88
The Subthalamic Nucleus becomes a Generator of Bursts in the Dopamine-Depleted State. Its High Frequency Stimulation Dramatically Weakens Transmission to the Globus Pallidus. Front Syst Neurosci (2011) 0.88
[Inhibition and working memory: effect of acute sleep deprivation on a random letter generation task]. Can J Exp Psychol (2003) 0.86
Disruption of the proprioceptive mapping in the medial wall of parkinsonian monkeys. Ann Neurol (2002) 0.84
Auditory temporal processing in Parkinson's disease. Neuropsychologia (2008) 0.84
Dopamine transporter knock-out mice are hypersensitive to 3-nitropropionic acid-induced striatal damage. Eur J Neurosci (2002) 0.83
Nocturnal sustained attention during sleep deprivation can be predicted by specific periods of subjective daytime alertness in normal young humans. J Sleep Res (2006) 0.82
Pattern of levodopa-induced striatal changes is different in normal and MPTP-lesioned mice. J Neurochem (2003) 0.82
Pretargeting for the implantation of stimulation electrodes into the subthalamic nucleus: a comparative study of magnetic resonance imaging and ventriculography. Neurosurgery (2006) 0.82
Dopamine-dependent long-term depression at subthalamo-nigral synapses is lost in experimental parkinsonism. J Neurosci (2013) 0.82